2025 Regular Session • Virginia Legislature
HB2106: Health insurance; prohibits pharmacy override for enrollee with sickle cell disease.
Legislative Summary
Health insurance; pharmacy override for enrollee with sickle cell disease; prohibited. Prohibits a health insurance carrier from requiring a pharmacy to override a denial code or to request an override in order to dispense a prescription drug for the treatment or management of pain to an enrollee who has been diagnosed with sickle cell disease.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/7/2025
Prefiled and ordered printed; Offered 01-13-2025 25101618D
House of Delegates
1/7/2025
Referred to Committee on Labor and Commerce
House of Delegates
1/14/2025
Assigned L & C sub: Subcommittee #1
House of Delegates
1/21/2025
Subcommittee recommends laying on the table (4-Y 3-N)
House of Delegates
2/5/2025
Left in Labor and Commerce
House of Delegates
Roll Call Votes
Subcommittee recommends laying on the table (4-Y 3-N)
1/21/2025
4
Yea
3
Nay
0
Not Voting
1
Absent
Result: PASSED
Status Information
Current Status
Introduced(1/7/2025)
Chamber
House of Delegates
Committee
Labor and Commerce(House of Delegates)
Sponsors
Republican: 1
Primary Sponsor
Otto Wachsmann
Republican